USPTO serial 76145143
GEL-DEL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- CASE, LEIGH CAROLINE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with GEL-DEL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
T Michael Davis
T MICHAEL DAVIS PATTERSON THUENTE SKAAR & CHRISTENSEN PA80 S 8TH STIDS CTR STE 4800MINNEAPOLIS, MN 55402-2100Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical carriers in the nature of protein matrix delivery devices, namely unit and multi-unit dose solid matrixes in the form of tablets, tubes, capsules, wafers, particles, sheets, lozenges and patches; cell growth pharmaceutical materials in the nature of cell scaffolding; vessels, namely blood and urinary vessels; skin, bone, cartilage and tissue grafts; coverings in the nature of bandages, surgical dressings, wound dressings, sutures, staples, medical device coatings; all for use with or as bioresorbable, partially bioresorbable and non-bioresorbable protein-based biocompatible medical devices and medical device materials incorporating protein matrix technology | ACTIVE | — |
| 010 | Stents; leads; delivery devices in the nature of medical tubing, transdermal drug delivery patches sold without medication, protein matrix bone, dental, ocular and orthopedic joint implants; cell growth devices in the nature of cell scaffolding; vessels, namely blood and urinary vessels; implantable and partially implantable tubes; skin and tissue replacements in the nature of artificial skin, bone, cartilage and tissue for surgical purposes, biological skin, bone, cartilage and tissue intended for subsequent bone, skin and cartilage implantation; all for use with or as bioresorbable, partially resorbable, and non-bioresorbable protein-based biocompatible medical devices and medical device materials incorporating protein matrix technology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 17, 2003 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 17, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 11, 2002 | CNCF | CONTINUATION OF FINAL REFUSAL MAILED | — |
| May 9, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 9, 2002 | PAPER RECEIVED | — | |
| Nov 13, 2001 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 30, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 27, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 16, 2001 | DOCK | ASSIGNED TO EXAMINER | — |